Brands Like GlaxoSmithKline Begin to Sell Generic Drugs - The New York Times

Haleon emerges from GSK consumer healthcare spin-off, Business

AbbVie, GSK cited as FTC tackles wrong Orange Book patents

GlaxoSmithKline and Pfizer to Merge Consumer Health Units - The New York Times

GSK licenses companies to make cheap copies of HIV prevention drug

Drug Goes From $13.50 a Tablet to $750, Overnight

Pfizer and GlaxoSmithKline combine consumer health care businesses

F.D.A. Names and Shames Drug Makers to Encourage Generic Competition - The New York Times

Who are the top 10 pharmaceutical companies in the world? (2023)

Generic drugs in the US are too cheap to be sustainable, experts say, Drugs

Taking A Look At The Special Situation With GlaxoSmithKline (NYSE:GSK)

History and heritage

GENERIC DRUGS IN BIGGER ROLE - The New York Times

Pressure builds on GSK with US filing for generic Advair

Opinion Our Generic Drug Supply Is Sick - The New York Times

GSK is taking control of Google data to find out more about customers